In the current study 49% of invasive cancers showed hOGG1 expression, which is roughly comparable to the figure of 62% reported previously in head and neck cancer, although a different grading system was used in that study (Fan et al, 2001). The gene discussed is OGG1; the disease is head and neck cancer.